Concepedia

Fabio Gelsomino

FG

40

Publications

3.7K

Citations

23

H-Index

2013

Active since

Affiliations

University of Modena and Reggio Emilia(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Sapienza University of Rome

Azienda Ospedaliera Sant'Andrea

Fabio Gelsomino is an author at University of Modena and Reggio Emilia specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2013–2024

40

Publications

40

Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer

Michael J. Overman, Sara Lonardi, Ka Yeung Mark Wong et al. · Journal of Clinical Oncology · 2018 · 2K citations · Full text

, , +18

Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142

Thierry André, Sara Lonardi, Ka Yeung Mark Wong et al. · Annals of Oncology · 2022 · 234 citations · Full text

Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer

Alessandro Passardi, Emanuela Scarpi, Luigi Cavanna et al. · Oncotarget · 2016 · 152 citations · Full text

Class 1, 2, and 3 <i>BRAF</i> -Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular Characterization

Marta Schirripa, Paola Biason, Sara Lonardi et al. · Clinical Cancer Research · 2019 · 104 citations · Full text

Oxaliplatin-Based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological Factors

Francesca Spada, Lorenzo Antonuzzo, Riccardo Marconcini et al. · Neuroendocrinology · 2016 · 91 citations · Full text

Rows per page

1–5 of 40